The fibroblast growth factor receptors 
tissues and cell lines and demonstrated that all of the cell lines studied expressed at least two different forms of the FGFR-1 at simila levels. Although muscle and heart express forms having either two [FGFR-1 short (FGFR-1S)J or three [FGFR-1 long (FGFR-1L)J Ig-like domains, the developing brain and adult brain express only mRNA encoding the longer form. The two forms of the receptor were characterized further by stably introducing expression vectors expressing them into Rat-2 fibroblasts and FDC-P1 myeloid cells. Treatment of the trandected Rat-2 cells with acidic FGF (aFGF) or basic FGF (bFGF) resulted in focus formation. The transformed phenotype was observed even without addition of lind after growth in culture for >2 months.
Cros4inking of 125I-labeed bFGF (12SI-bFGF) to Rat-2 cells expressing either FGFR-1L or FGFR-1S yielded two similar complexes of 150 and 110 kDa. Although Rat-2 cells expre g FGFR-1L yielded similar complexes with 125I-labeled aFGF (12SI-aFGF), only the 150-kDa complex was formed with cells expressing FGFR-1S. The 150-kDa complex was also observed when 125I-aFGF or 12'I-bFGF was cross-linked to FDC-P1 cells expressing FGFR-1L. Signiflcantiy, these complexes were only observed when heparin was present in the cross-linking reaction. FDC-P1 cells expressing FGFR-1 bound aFGF and bFGF with high affinity but only in the presence ofheparin. The factor dependence of these cells could be switched from interleukin 3 to FGF in the presence of heparin.
The finding that the fibroblast growth factor receptors (FGFRs) form a family consisting of at least four different genes bearing significant homology to one another (1) raises fundamental problems in developmental and cellular biology. For example, do each of the seven known fibroblast growth factors (FGFs) recognize a specific receptor, or can each growth factor bind to more than one receptor? The most intensively studied members of the FGF family are the acidic FGF (aFGF) and basic FGF (bFGF). Both growth factors have been shown to promote mitogenesis and differentiation of a wide variety of neuroectodermal and mesodermal cells (2) (3) (4) (5) (6) . These in vitro effects may reflect the multiple roles of FGFs during development and in the mature animal, such as (i) proliferation observed in early neural development, (ii) the maintenance of differentiated cells such as neurons, and (iiH)
tissue induction events such as those observed during mesoderm formation. Early binding assays and cross-linking experiments with radiolabeled aFGF and bFGF suggested that both ligands can bind to the same receptor (7) . More recent binding experiments using 3T3 cells transfected with either of two closely related FGFR cDNAs, flg (FGFR-1) or bek (FGFR-2), demonstrated that these receptors can bind both ligands with similar affinity (8) . Moreover, competition experiments showed that aFGF and bFGF bind to the same site on each receptor (8) .
We have previously demonstrated by cDNA cloning that the mouse FGFR-1 exists in at least two forms translated from alternately spliced mRNAs. The longer form [FGFR-1 long (FGFR-1L)] contains three immunoglobulin-like (Iglike) extracellular domains, whereas the shorter form [FGFR-1 short (FGFR-1S)] is identical except that it lacks a region encoding the first Ig-like domain (1) . Similar forms of the FGFR-1 have also been found for the human homologue (9) and for FGFR-2 (8, 10) . Binding studies using Chinese hamster ovary cells expressing the short form of the murine FGFR-1 cDNA and bFGF and Kaposi FGF (K-FGF) indicated that both ligands bind to the same receptor and that they compete with each other in the binding assay. The affinity for bFGF was, however, higher than for K-FGF (11) . It has been demonstrated that the keratinocyte growth factor receptor, equivalent to FGFR-2 but lacking the first immunoglobulin and acidic domains, bound aFGF and keratinocyte growth factor with similar affinities but did not bind bFGF (10) . On the other hand, FGFR-2 containing all three Ig-like domains can bind aFGF and bFGF, although aFGF binds with higher affinity (8) . Two additional members containing three Ig-like extracellular domains have recently been cloned. In experiments using aFGF and bFGF, oocytes expressing FGFR-3 responded to both ligands (12) , whereas FGFR4 only bound aFGF (13 (15) . To produce helper-free viruses the DNA constructs were electroporated into qi-2 cells (6). G418-resistant colonies were expanded and the integration of the FGFR-1 proviruses was determined by Southern blot analysis. Rat-2 FGFR-1 cell lines were generated by transfection of pMPZenNeo (FGFR-1) DNA construct using lipofection reagent (BRL). FDC-P1 FGFR-1 cell lines were generated by infection of FDC-P1 cells with MPZenNeo (FGFR-1) virus as described (13) . shaking, after which they were washed once with 0.5 M NaCl in PBS followed by three washes with PBS. The cross-linking agent disuccinimidyl suberate (Pierce) was added to the cells at a final concentration of 0.2 mM in PBS, and the dishes were incubated for 30 min at 37°C. The cells were washed twice with PBS, scraped off in ice-cold PBS, pelleted, and then solubilized in ice-cold lysis buffer (16) . After 10 min on ice, the nuclei were removed by centrifugation and an aliquot was analyzed by 10% SDS/PAGE. Cross-linking of 125I-aFGF and 125I-bFGF to FDC-P1 cells was carried out in a similar way to that performed with Rat-2 cells except that the experiments were performed with 1 x 107 cells in 2 ml of medium.
Growth of FDC-P1 Cells Expressing FGFR-1. Cells were grown in 24-well Costar plates in 1 ml of DMEM/10% FCS containing either W3CM or 20 ng of human recombinant aFGF per ml (Promega) or bFGF per ml (Boehringer Mannheim) in the presence or absence of 10 units of heparin per ml or heparin alone. Cell counts were performed every 24 hr.
RESULTS

Expression of the Two Forms of the FGFR-1 in Different
Mouse Tissues and Cell Lines. To study the expression patterns of the two forms of the FGFR-1 in various tissues and cell lines, we have employed RNase protection analysis. The probe used in these experiments spanned the region spliced out in FGFR-1S and could detect both forms of the FGFR-1 mRNA (Fig. 1B) . In addition, the probe encoded arginines at positions 148 and 149 of the FGFR-1 that were absent in some ofthe cDNA clones isolated (1) . RNA Rat-2 all coexpress the two different forms of the FGFR-1 mRNA with and without arginines 148 and 149 (Fig. 1A) . The expression of these two forms of the FGFR-1 is not confined to cell lines, as they are also expressed in normal tissues such as heart and muscle (data not shown). Interestingly, the developing brain (embryonic day 10 to adult) expressed only the FGFR-1L mRNA. No protected species of either form of the FGFR-1 mRNA were observed in thymus (not shown) or FDC-P1 cell RNA (Fig. LA) . Expression of FGFR-1 in Rat-2 Cells Induces Transformation. cDNA clones coding each of the long and short forms of FGFR-1 were cloned into the retroviral expression vector pMPZenNeo (6) and transfected into Rat-2 cells. Rat-2 cells were chosen because they express a very low level of FGFR-1 mRNA compared to other fibroblast cell lines such as 4,-2 (Fig. 1A) . A striking phenotypic change ( to form foci, cells cultured for -2 months retained a transformed phenotype in the absence of FGF treatment. Moreover, when late-passage Rat-2 FGFR-1-expressing cell lines were injected intraperitoneally into syngeneic recipients (Fischer rats), large tumors formed within 3 weeks in all four injected rats. Untransfected Rat-2 cells did not form foci at any stage of passaging. These data suggest that a second event resulted in factor-independent transformation of the transfected cells and that FGFR-1 may be implicated in neoplasia.
Growth Requirements of FDC-P1 Cells Expressing FGFR-1. We infected FDC-P1 myeloid cells with FGFR-1 bearing retrovirus because these cells fail to express any endogenous FGFR-1 (Fig. LA) or extracellular matrix and require growth factors such as granulocyte/macrophage colony-stimulating factor (GM-CSF) or IL-3 for their growth. We examined the effect of aFGF, bFGF, and heparin on their ability to proliferate indefinitely. Parental FDC-P1 cells remained viable only in the presence of W3CM. When these cells were transferred to medium lacking IL-3, their viability declined rapidly, and no live cells remained after 48 hr. In contrast, when FDC-P1 FGFR-1 cells were grown in medium lacking IL-3 but containing aFGF or bFGF and heparin, the cells survived and grew slowly for at least 6 days. In the presence of either FGF or heparin alone, they died within 48 hr. Growth in the presence of FGF and heparin remained slow for 2 weeks (Fig. 3 ) but, after this initial adaptation period, the FDC-P1 cells expressing FGFR-1 could be grown continuously in medium containing FGF and heparin and became FGF dependent.
Binding of 125I-FGF to FDC-P1 Cells Expressing FGFR-1.
As FDC-P1 cells do not express FGFR-1 mRNA, they do not bind aFGF or bFGF in the presence or absence of heparin. Their receptor-bearing derivatives, FDC-P1 FGFR-1L and FDC-P1 FGFR-1S, which express high levels of FGFR-1 mRNA, also failed to bind either ligand in the absence of heparin. High-affinity binding was obtained only when heparin was added to the binding buffer. No differences were observed in the binding of 125I-bFGF to the two lines. Hence the two forms of FGFR-1 have a similar binding affinity for bFGF. Moreover, binding of 125I-aFGF to FDC-P1 FGFR-1L cells gave a similar binding pattern to that obtained for 125I-bFGF (Fig. 4 and data not shown) .
Cross-6nking of125I-aFGF and '25I-bFGF to Rat-2 and FDC-P1 Rat-2 cells (Fig. SB) .
In the absence of heparin, FDC-P1 cells expressing FGFR-1L were not able to cross-link either 125I-aFGF or 125I-bFGF. However, when cross-linking was performed in the presence of 10 units of heparin per ml, complexes of 150 kDa were obtained. This is consistent with the absolute requirement of heparin for FGF binding and cell growth described above. Again, the complex formation was inhibited by the presence of an excess of either unlabeled aFGF or unlabeled bFGF ( 
DISCUSSION
We have previously described the cloning and sequencing of two forms of FGFR-1 containing either two or three Ig-like domains (1). These full-length cDNA clones were isolated from a cDNA library prepared from the immortalized neuroepithelial cell line NZen37 (6) . Northern blot analysis demonstrated that the FGFR-1 mRNA is expressed in all neuroepithelial and fibroblast cell lines examined as well as in the developing and mature mouse brain. However, that technique was not sensitive enough to reveal significant levels ofmRNA in tissues such as heart and spleen (1) . RNase protection analysis provides a more sensitive technique for analyzing specific mRNA sequences and can distinguish between transcripts differing by only a few nucleotides. The RNase protection analysis demonstrated that both forms of FGFR-1 exist in cultured cells as well as in normal adult tissues such as heart and muscle. Curiously, FGFR-1S FGFs (26) , and recently a cDNA clone encoding such a protein was isolated by selection of cells expressing this cDNA on a plate coated with bFGF (27) . Moreover, all of the FGFs except int-2 bind to heparin and are collectively known as heparin binding growth factors (28, 29) . Chinese hamster ovary cells defective in the metabolism of glycosaminoglycans and lacking HSPG are not capable of binding FGF. When a FGFR cDNA was introduced into them, FGF binding was restored only after addition of heparin (30) . As previously suggested, it is possible that the binding of heparin or HSPG to FGF stabilizes the tertiary structure of the FGFs in such a way that it promotes high-affinity binding to their receptors. Indeed, the biological activity of aFGF can be increased up to 100-fold by addition of heparin (31) .
As mentioned above, FDC-P1 cells depend on either IL-3 or GM-CSF for their growth. Removal of these growth factors from the growth medium resulted in total cell death within 48 hr. FDC-P1 FGFR-1L cells are also factor dependent but IL-3 or GM-CSF can be replaced by heparin plus aFGF or bFGF. The growth of the cells in FGF and heparin is much slower than in IL-3 or GM-CSF because a large percentage of the cells differentiate into mature granulocytes and only a relatively small proportion can replicate (M.L. and O.B., unpublished results). The FDC-P1 FGFR-1 cells offer an excellent system for studying the second messenger systems involved in cellular growth and differentiation mediated by the FGFs and their receptors.
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